Abeona Therapeutics Inc.
Price Action
Technical Summary
CONSOLIDATINGAbeona Therapeutics Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 43), showing significant lag compared to the market leaders. Earnings contraction of 57% provides fundamental context to the price action. Investors should exercise caution due to high volatility (53% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $5.47 | +5.55% | ABOVE |
| 50 SMA | $5.04 | +14.45% | ABOVE |
| 100 SMA | $5.11 | +12.92% | ABOVE |
| 150 SMA | $5.07 | +13.86% | ABOVE |
| 200 SMA | $5.40 | +6.82% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ABEO in an uptrend right now?
ABEO has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is ABEO overbought or oversold?
ABEO's RSI (14) is 69. The stock is in neutral territory, neither overbought nor oversold.
Is ABEO outperforming the market?
ABEO has a Relative Strength (RS) Rating of 43 out of 99. ABEO is currently lagging the broader market.
Where is ABEO in its 52-week range?
ABEO is trading at $5.77, which is 77% of its 52-week high ($7.54) and 50% above its 52-week low ($4.00).
How volatile is ABEO?
ABEO has a Beta of 1.34 and 52-week volatility of 53%. It's more volatile than the S&P 500 - expect bigger swings.